| 0 (0%) | 02-21 18:48 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 24.72 | 1-year : | 28.88 |
| Resists | First : | 21.17 | Second : | 24.72 |
| Pivot price | 20.66  |
|||
| Supports | First : | 19.8 |
Second : | 18.95 |
| MAs | MA(5) : | 20.85 |
MA(20) : | 20.69 |
| MA(100) : | 19.9 |
MA(250) : | 19.7 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 72.9 |
D(3) : | 78.3 |
| RSI | RSI(14): 56.7 |
|||
| 52-week | High : | 22.09 | Low : | 17.2 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MCI ] has closed below upper band by 39.1%. Bollinger Bands are 57.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 20.94 - 21.05 | 21.05 - 21.13 |
| Low: | 20.33 - 20.44 | 20.44 - 20.53 |
| Close: | 20.58 - 20.75 | 20.75 - 20.9 |
Sat, 21 Feb 2026
MCI cracks down on violations; records 47,000 complaints in 2025 - Times Kuwait
Tue, 17 Feb 2026
Pacific Defense Delivers First CMFF MCI Systems Months After Award, Accelerating U.S. Army CMOSS Adoption - Business Wire
Mon, 16 Feb 2026
Investigational Therapy ALZ-801 Shows Clinical Efficacy in MCI Stage of Alzheimer Disease - Pharmacy Times
Fri, 13 Feb 2026
Digital health interventions cut symptoms of depression among older adults with MCI, study finds - McKnight's Long-Term Care News
Thu, 11 Dec 2025
MCI GPP: ensembling a global model- and climate-independent gross primary productivity for 2001–2023 - Nature
Fri, 28 Nov 2025
Market Force Information® Parent MCI Taps FEMA/DHS Veteran Executive Mark Misczak as President; Spins Out Tier-5 AiCX.com Division - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 20 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 18.4 (%) |
| Shares Short | 20 (K) |
| Shares Short P.Month | 23 (K) |
| EPS | 1.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 17.1 |
| Profit Margin | 77.8 % |
| Operating Margin | 84 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 9.1 % |
| Qtrly Rev. Growth | -10.9 % |
| Gross Profit (p.s.) | 2 |
| Sales Per Share | 2 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -21.9 % |
| Operating Cash Flow | 13 (M) |
| Levered Free Cash Flow | 26 (M) |
| PE Ratio | 13.21 |
| PEG Ratio | 0 |
| Price to Book value | 1.21 |
| Price to Sales | 10.33 |
| Price to Cash Flow | 33.37 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 1.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|